Transcendent Capital Group LLC Journey Medical Corp Transaction History
Transcendent Capital Group LLC
- $174 Billion
- Q2 2024
A detailed history of Transcendent Capital Group LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Transcendent Capital Group LLC holds 500 shares of DERM stock, worth $2,350. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$2,350% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DERM
# of Institutions
37Shares Held
3.11MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$4.06 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA310KShares$1.46 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.295KShares$1.39 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny264KShares$1.24 Million0.0% of portfolio
-
American Financial Group Inc180KShares$846,0000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $54.5M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...